Multiple Assemblies exist for SMTL entry 5u7i
PDE2 catalytic domain complexed with inhibitors; X-RAY DIFFRACTION 2.00 Å

	SMTL ID 5u7i.1 Ligands 4-[3-(4-methoxyphenoxy)azetidin-1-yl]-1-methyl-3-(2-methylpropyl)-1H-pyrazolo[3,4-d]pyrimidine; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5u7i.2 Ligands 4-[3-(4-methoxyphenoxy)azetidin-1-yl]-1-methyl-3-(2-methylpropyl)-1H-pyrazolo[3,4-d]pyrimidine; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5u7i.3 Ligands 4-[3-(4-methoxyphenoxy)azetidin-1-yl]-1-methyl-3-(2-methylpropyl)-1H-pyrazolo[3,4-d]pyrimidine; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5u7i.4 Ligands 4-[3-(4-methoxyphenoxy)azetidin-1-yl]-1-methyl-3-(2-methylpropyl)-1H-pyrazolo[3,4-d]pyrimidine; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer